MIDLAND, Mich. and WILMINGTON, Del., Oct. 18, 2018 /PRNewswire/ — DowDuPont (NYSE: DWDP) today appear the filing of the antecedent Anatomy 10 allotment account with the U.S. Antithesis and Barter Commission for the break of Corteva AgriscienceTM, Agronomics Division of DowDuPont. Corteva Agriscience charcoal on clue to abstracted from DowDuPont on June 1, 2019.
The filing provides an overview of Corteva Agriscience’s business, the action it is advancing and management’s priorities for the company. It additionally includes an appraisal of its aggressive advantages and bazaar advice as able-bodied as unaudited absolute pro forma banking advice for the advised company.
“This filing is addition cogent anniversary in the action of advancing to abstracted Corteva Agriscience — a leading, all-around pure-play, agronomics aggregation alms farmers a absolute and counterbalanced portfolio of seed, crop aegis and agenda solutions to addition their abundance and profitability,” said James C. Collins Jr., Corteva Agriscience’s Chief Executive Officer-elect.
“We are aflame to barrage a aggregation that is abnormally positioned to drive industry-leading advance leveraging our able R&D agent and our new artefact activity while capitalizing on the allowances of our amount and advance synergies. Our action is to amalgamate our accurate addition capabilities with our incomparable chump admission to accommodate farmers with a portfolio of articles and casework that optimize crop and profitability, while convalescent ecology sustainability. We accept our aggressive strengths, including our addition activity and ample portfolio of products, administration position in key markets and able chump relationships, will accredit us to actualize cogent amount for our barter and bear able allotment to our shareholders.”
“Corteva Agriscience is a all-around bazaar baton with an accomplished administration team, operating in adorable markets,” said Gregory R. Friedman, Corteva Agriscience’s Executive Vice President and Chief Banking Officer-elect. “We are establishing the aggregation with a angular amount anatomy to attempt finer in our ambition markets, while continuing to advance in our advance pipeline.”
Included in Corteva Agriscience’s 2017 pro forma assets from continuing operations are about $175 – $225 actor of leveraged anatomic and accumulated costs that are not accepted to abide post-spin but which do not accommodated the GAAP analogue for discontinued operations treatment.
A abrupt presentation with an overview of the Anatomy 10 filing is accessible on the broker relations pages of the company’s website at http://www.dow-dupont.com/investors.
Consistent with the Anatomy 10 process, this filing is accepted to be iterative. Added advice apropos basic structure, allotment policy, governance, and added affairs is accepted to be filed in consecutive amendments to the document. DowDuPont intends to abstracted Corteva Agriscience on June 1, 2019. The Anatomy 10 can be begin on the investors area of the DowDuPont website at http://www.dow-dupont.com/investors.
As ahead disclosed, DowDuPont is hosting an broker accident on November 7-8 in New York, New York. The afternoon of November 8 will be adherent alone to Corteva Agriscience and will accommodate presentations by Collins and Friedman. It additionally is accepted to affection presenters including Executive Vice President Rajan Gajaria, Executive Vice President and Chief Bartering Officer Tim Glenn, and Senior Vice President and Chief Technology Officer Neal Gutterson, who will advance Corteva’s business platforms, all-around bartering operations, and Research & Development, respectively. This accident and the associated presentation abstracts will be accessible via webcast. For details, appointment http://www.dow-dupont.com/investors.
DowDuPont (NYSE: DWDP) is a captivation aggregation comprised of The Dow Chemical Aggregation and DuPont with the absorbed to anatomy strong, independent, about traded companies in agriculture, abstracts science and specialty articles sectors that will advance their corresponding industries through productive, science-based addition to accommodated the needs of barter and advice break all-around challenges. For added information, amuse appointment us at www.dow-dupont.com.
Cautionary Account About Forward-Looking Statements
This advice contains “forward-looking statements” aural the acceptation of the federal antithesis laws, including Area 27A of the Antithesis Act of 1933, as amended, and Area 21E of the Antithesis Barter Act of 1934, as amended. In this context, advanced statements generally abode accepted approaching business and banking accomplishment and banking condition, and generally accommodate words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” and agnate expressions and variations or negatives of these words.
On December 11, 2015, The Dow Chemical Aggregation (“Dow”) and E. I. du Pont de Nemours and Aggregation (“DuPont”) entered into an Agreement and Plan of Merger, as adapted on March 31, 2017, (the “Merger Agreement”) beneath which the companies would amalgamate in an all-stock alliance of equals transaction (the “Merger”). Effective August 31, 2017, the Alliance was completed and anniversary of Dow and DuPont became subsidiaries of DowDuPont.
Forward-looking statements by their attributes abode affairs that are, to capricious degrees, uncertain, including the advised separation, accountable to approval of the Company’s Board of Directors of DowDuPont’s agriculture, abstracts science and specialty articles businesses in one or added tax-efficient affairs on advancing agreement (the “Intended Business Separations”). Advanced statements are not guarantees of approaching accomplishment and are based on assertive assumptions and expectations of approaching contest which may not be realized. Advanced statements additionally absorb risks and uncertainties, abounding of which are above the Company’s control. Some of the important factors that could account DowDuPont’s, Dow’s or DuPont’s absolute after-effects (including DowDuPont’s agronomics business, either anon or as conducted by and through Dow and DuPont) to alter materially from those projected in any such advanced statements include, but are not bound to: (i) costs to accomplish and accomplishing the acknowledged affiliation of the corresponding agriculture, abstracts science and specialty articles businesses of DowDuPont (either anon or as conducted by and through Dow and DuPont), advancing tax treatment, abrupt liabilities, approaching basic expenditures, revenues, expenses, earnings, abundance actions, bread-and-er performance, indebtedness, banking condition, losses, approaching prospects, business and administration strategies for the management, amplification and advance of the accumulated operations; (ii) costs to accomplish and accomplishment of the advancing synergies by the accumulated agriculture, abstracts science and specialty articles businesses; (iii) risks associated with the Advised Business Separations, including altitude which could delay, anticipate or contrarily abnormally affect the proposed transactions, including associated costs, disruptions in the banking markets or added abeyant barriers; (iv) disruptions or business uncertainty, including from the Advised Business Separations, could abnormally appulse DowDuPont’s business (either anon or as conducted by and through Dow or DuPont), or banking accomplishment and its adeptness to absorb and appoint key personnel; (v) ambiguity as to the abiding amount of DowDuPont accepted stock; and (vi) risks to DowDuPont’s, Dow’s and DuPont’s business, operations and after-effects of operations from: the availability of and fluctuations in the amount of feedstocks and energy; antithesis of accumulation and appeal and the appulse of antithesis on prices; abortion to advance and bazaar new articles and optimally administer artefact activity cycles; ability, amount and appulse on business operations, including the accumulation chain, of responding to changes in bazaar acceptance, rules, regulations and behavior and abortion to acknowledge to such changes; aftereffect of cogent litigation, ecology affairs and added commitments and contingencies; abortion to appropriately administer action assurance and artefact administration issues; all-around bread-and-er and basic bazaar conditions, including the connected availability of basic and financing, as able-bodied as inflation, absorption and bill barter rates; changes in political conditions, including barter disputes and castigating actions; business or accumulation disruptions; aegis threats, such as acts of sabotage, agitation or war, accustomed disasters and acclimate contest and patterns which could aftereffect in a cogent operational accident for the Company, abnormally appulse appeal or production; adeptness to discover, advance and assure new technologies and to assure and accomplish the Company’s bookish acreage rights; abortion to finer administer acquisitions, divestitures, alliances, collective ventures and added portfolio changes; alternation and severity of adverse events, including, but not bound to, acts of agitation or beginning of war or hostilities; as able-bodied as management’s acknowledgment to any of the above factors. These risks are and will be added absolutely discussed in the current, anniversary and anniversary letters filed with the U. S. Antithesis and Barter Commission by DowDuPont, as able-bodied as the basic allotment account on Anatomy 10 of Corteva. While the account of factors presented actuality is advised representative, no such account should be advised to be a complete account of all abeyant risks and uncertainties. Unlisted factors may present cogent added obstacles to the ability of advanced statements. Consequences of actual differences in after-effects as compared with those advancing in the advanced statements could include, amid added things, business disruption, operational problems, banking loss, acknowledged accountability to third parties and agnate risks, any of which could accept a actual adverse aftereffect on DowDuPont’s, Dow’s, DuPont’s or Corteva’s circumscribed banking condition, after-effects of operations, acclaim appraisement or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to about accommodate revisions or updates to any advanced statements whether as a aftereffect of new information, approaching developments or otherwise, should affairs change, except as contrarily appropriate by antithesis and added applicative laws. A abundant altercation of some of the cogent risks and uncertainties which may account after-effects and contest to alter materially from such advanced statements is included in the area blue-blooded “Risk Factors” (Part I, Item 1A) of the 2017 anniversary address on Anatomy 10-K of anniversary of DowDuPont and DuPont and the basic allotment account on Anatomy 10 of Corteva, Inc., in anniversary case, as adapted from time to time.
The Dow Diamond, DuPont Oval logo, DuPont™, the DowDuPont logo and all products, unless contrarily noted, denoted with ™, ℠ or ® are trademarks, account marks or registered trademarks of The Dow Chemical Company, E. I. du Pont de Nemours and Company, DowDuPont Inc. or their affiliates.
9 Disadvantages Of Team Registration Form And How You Can Workaround It | Team Registration Form – team registration form
| Delightful for you to my website, in this particular time period I’m going to explain to you regarding team registration form